I. Sipahi Et Al. , "Dabigatran's 'Real-World' Data About Risk of Myocardial Infarction and Gastrointestinal Bleeding Contradicts With Randomized Trials," JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY , vol.62, no.10, pp.945-946, 2013
Sipahi, I. Et Al. 2013. Dabigatran's 'Real-World' Data About Risk of Myocardial Infarction and Gastrointestinal Bleeding Contradicts With Randomized Trials. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY , vol.62, no.10 , 945-946.
Sipahi, I., Celik, S., & Akyol, A., (2013). Dabigatran's 'Real-World' Data About Risk of Myocardial Infarction and Gastrointestinal Bleeding Contradicts With Randomized Trials. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY , vol.62, no.10, 945-946.
Sipahi, Ilke, Seden Celik, And AHMET AKYOL. "Dabigatran's 'Real-World' Data About Risk of Myocardial Infarction and Gastrointestinal Bleeding Contradicts With Randomized Trials," JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY , vol.62, no.10, 945-946, 2013
Sipahi, Ilke Et Al. "Dabigatran's 'Real-World' Data About Risk of Myocardial Infarction and Gastrointestinal Bleeding Contradicts With Randomized Trials." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY , vol.62, no.10, pp.945-946, 2013
Sipahi, I. Celik, S. And Akyol, A. (2013) . "Dabigatran's 'Real-World' Data About Risk of Myocardial Infarction and Gastrointestinal Bleeding Contradicts With Randomized Trials." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY , vol.62, no.10, pp.945-946.
@article{article, author={Ilke Sipahi Et Al. }, title={Dabigatran's 'Real-World' Data About Risk of Myocardial Infarction and Gastrointestinal Bleeding Contradicts With Randomized Trials}, journal={JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY}, year=2013, pages={945-946} }